Edit noodls
11 Nov 2013
Nobuo Hanai, "Kyowa Hakko Kirin") announced today the discontinuation of its Phase 2 clinical studies evaluating a small molecule compound, bardoxolone methyl (RTA 402)*1 licensed from Reata Pharmaceuticals, Inc ... In the meantime, Kyowa Hakko Kirin has been considering a new development program of bardoxolone methyl (RTA 402) in CKD patients with type 2 diabetes ... *1 Bardoxolone methyl (RTA 402)....(size: 3.9Kb)
Edit noodls
11 Nov 2013
(Source ... Lin Shuangjun ... The research not only unveiled the formation of two kinds of b-methyl-tryptophan secondary metabolites in nature, but also provided a tool for the synthesis of b-methyl-tryptophan and for the exploration of natural products which contain b-methyl-tryptophan unit ... (noodl....(size: 1.5Kb)
Edit Stockhouse
11 Nov 2013
Illumina, Inc. (NASDAQ.ILMN) today announced it has appointed Francis deSouza to the role of President. Mr ... Mr ... Mr ... Before his years at IMlogic and Symantec, Mr ... Mr ... Mr. deSouza will join the Illumina team in December. About Illumina ... We provide innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA, and protein....(size: 2.8Kb)
Edit Business Wire
11 Nov 2013
AUSTIN, Texas--(BUSINESS WIRE)--Asuragen, Inc., a molecular diagnostic company using genomics to drive better patient management, will present at the upcoming Association for Molecular Pathology (AMP) Annual Meeting on Genomic Medicine, November 13-16th in Phoenix, AZ ... Dr ... In addition, a study describing a simplified PCR-only workflow for FMR1 methylation analysis evaluated by two European laboratories will be reported ... About Asuragen ....(size: 5.4Kb)
Edit noodls
11 Nov 2013
(Source. Illumina Inc). SAN DIEGO--(BUSINESS WIRE)--Nov. 11, 2013-- Illumina, Inc. (NASDAQ.ILMN) today announced it has appointed Francis deSouza to the role of President. Mr ... Mr ... Mr ... Before his years at IMlogic and Symantec, Mr ... Mr ... Mr ... We provide innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA, and protein ... or....(size: 3.4Kb)
Edit PR Newswire
11 Nov 2013
A new fine chemical propels CAS REGISTRY past the 75 million mark. Download image. 3-(Cycloheptyloxy)-6-methyl-N-(1-methylethyl)-2-pyridinemethanamine -- CAS Registry Number(R). 1470595-42-6. (PRNewsFoto/Chemical Abstracts Service (CAS)). COLUMBUS, Ohio, Nov ... CAS is the only organization in the world whose objective is to find, collect and organize all publicly disclosed chemical substance information ... (Photo ... About CAS ... RELATED LINKS ... ....(size: 4.7Kb)
Edit The Examiner
09 Nov 2013
New study points to statins as a possible treatment in Rett Syndrome. Rett Syndrome is the most physically disabling of the autism spectrum disorders ... each year. Mutations in a gene called MECP2 (methyl-CpG-binding protein 2) were identified as the cause of Rett Syndrome in 1999. The new study screened for randomly induced mutations in genes that modify the effect of the Rett gene, MECP2 (methyl-CpG-binding protein 2), in a mouse model....(size: 7.3Kb)
Edit PNAS
08 Nov 2013
CcrM is transiently present near the end of DNA replication when it rapidly methylates the adenine in hemimethylated GANTC sequences. The timing of transcription of two master regulator genes and two cell division genes is controlled by the methylation state of GANTC sites in their promoters ... The methylation state of ......(size: 1.6Kb)
Edit Business Wire
08 Nov 2013
MOUNT LAUREL, N.J.--(BUSINESS WIRE)--PMC Group N.A., Inc ... With product trade names such as ADVASTAB™, ADVAWAX™, ADVALUBE™, ADVAPAK™, Thermolite®, BAION™, CrystalWax®, Kemamide® and Kemester®, PMC Group offers the broadest portfolio of vinyl additives in the industry --- from methyl, butyl and octyl tin stabilizers and metallic stearates to a variety of specialty waxes and lubricants ... About PMC ... Business Wire article page ... ....(size: 3.5Kb)
Edit ICIS
08 Nov 2013
  . By Ong Sheau Ling. SINGAPORE (ICIS)--Spot methyl tertiary-butyl ether (MTBE) prices in Asia plunged to a 28-month low this week, tracking the slump in Brent crude and gasoline numbers, market players said on Friday ... Crude futures are generally trading lower despite a late-week recovery because of a build-up in crude oil inventories, especially in the Gulf Coast refining region, coupled with a stronger US dollar ... ....(size: 2.7Kb)
Edit noodls
08 Nov 2013
(Source. Government of Singapore) SCIENTIFIC RELEASE. 8 NOVEMBER 2013. A*STAR SCIENTISTS UNCOVER POTENTIAL DRUG TARGET TO NIP CANCER IN THE BUD. This discovery could eradicate cancers more effectively and prevent relapses. 1 ... 2 ... October online issue of Cancer Cell, under the title, "Wip1 controls global heterochromatin silencing via ATM/BRCA1-dependent DNA methylation" by Doria Filipponi1, Julius Muller1, Alexander Emelyanov1 and Dmitry V....(size: 5.0Kb)
Edit PNAS
07 Nov 2013
Abstract ... We investigated the mechanisms that regulate hsERVPRODH enhancer activity ... The enhancer activity of hsERVPRODH is regulated by methylation, and in an undermethylated state it can up-regulate PRODH expression in the hippocampus ... ....(size: 1.1Kb)
Edit Business Wire
07 Nov 2013
DUBLIN--(BUSINESS WIRE)--Research and Markets (http.//www.researchandmarkets.com/research/mfk4fv/cf101_dry_eye) has announced the addition of the "CF101 (Dry Eye Syndrome) - Forecast and Market Analysis to 2022" report to their offering ... It is a novel A3AR agonist, generically known as IB-MECA (methyl 1-[N6-(3-iodobenzyl)-adenin-9-yl]-b-D-ribofuronamide) ... Scope ... - Sales forecast for CF-101 for the top two countries from 2012 to 2022 ... ....(size: 3.9Kb)